Drug intelligence / Profile preview

symphytum herb extract

Development stage
Phase 3
Lead developer
Harras Pharma Curarina
Administration
Topical
01

Overview

Symphytum herb extract is a topical botanical preparation derived from a specifically cultivated variety of comfrey (Symphytum x uplandicum Nyman 'Harras') that is devoid of detectable toxic pyrrolizidine alkaloids. Developed by HARRAS Pharma Curarina, the extract is formulated as a 10% cream (marketed under the brand name Traumaplant) containing a 2.5:1 aqueous-ethanolic pressed concentrate of freshly harvested comfrey herb. It is indicated for wound healing impairment, including superficial skin abrasions, wounds, and pressure sores, as well as blunt traumas, muscle pain, and joint complaints. The therapeutic effects are attributed to its multi-component phytochemical profile, which includes key bioactive compounds such as allantoin, rosmarinic acid, salvianolic acid, and choline, which collectively promote wound healing, anti-inflammatory, and analgesic effects. It has been evaluated in Phase 3 clinical trials in children for accelerating the healing of superficial skin abrasions.

Brand names
Traumaplant
Other names
Symphytum x uplandicum herb extractcomfrey herb extractSymphytum herb extract cream 10%

Beyond the preview

Go deeper on symphytum herb extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on symphytum herb extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call